Expanding the arsenal of drugs against COVID-19 by Hirokazu Tamamura
Research Video
Paper Information
Potent and biostable inhibitors of the main protease of SARS-CoV-2
Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Miyuki Nakayama, Takato Onishi, Hiroki Nakano, Naoya Wada, Miki Hori, Kouki Shinohara, Yutaro Miura, Takuma Kawada, Hironori Hayashi, Shin-ichiro Hattori , Haydar Bulut, Debananda Das, Nobutoki Takamune, Naoki Kishimoto, Junji Saruwatari, Tadashi Okamura, Kenta Nakano, Shogo Misumi, Hiroaki Mitsuya and Hirokazu Tamamura
Publication: iScience
Publication Date: 18 November, 2022
DOI: 110.1016/j.isci.2022.105365
Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Miyuki Nakayama, Takato Onishi, Hiroki Nakano, Naoya Wada, Miki Hori, Kouki Shinohara, Yutaro Miura, Takuma Kawada, Hironori Hayashi, Shin-ichiro Hattori , Haydar Bulut, Debananda Das, Nobutoki Takamune, Naoki Kishimoto, Junji Saruwatari, Tadashi Okamura, Kenta Nakano, Shogo Misumi, Hiroaki Mitsuya and Hirokazu Tamamura
Publication: iScience
Publication Date: 18 November, 2022
DOI: 110.1016/j.isci.2022.105365
Correspondence to
Hirokazu Tamamura, Professor
E-mail: tamamura.mr(at)tmd.ac.jpDepartment of Medicinal Chemistry,
Institute of Biomaterials and Bioengineering,
Tokyo Medical and Dental University(TMDU)
＊Please change (at) in e-mail addresses to @ on sending your e-mail to contact personnels.